Sign up to save your podcasts
Or
Share Attacking the Cancer Cell: Advances in CAR T-Cell Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Attacking the Cancer Cell: Advances in CAR T-Cell Therapy
Carlos Silva, MD and Elissa
Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial Healthcare System in Pembroke Pines, Florida. In this episode, we explore the latest advances and what the future holds for CAR T-cell therapy.
This comprehensive view of CAR T-cell therapy will give blood cancer patients and their families hope. Through the utilization of targeted therapies, we can now see a future filled with better outcomes and potential cures.
DOWNLOAD TRANSCRIPT
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
Additional LLS Support Resources:
Support for this program is provided by: Allogene Therapeutics; Bristol Myers Squibb; CRISPR Therapeutics Ltd; Janssen Oncology & Legend Biotech; Kite, A Gilead Company and Novartis Pharmaceuticals Corp.
View all episodes
By The Leukemia & Lymphoma SocietyCarlos Silva, MD and Elissa
Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial Healthcare System in Pembroke Pines, Florida. In this episode, we explore the latest advances and what the future holds for CAR T-cell therapy.
This comprehensive view of CAR T-cell therapy will give blood cancer patients and their families hope. Through the utilization of targeted therapies, we can now see a future filled with better outcomes and potential cures.
DOWNLOAD TRANSCRIPT
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
Additional LLS Support Resources:
Support for this program is provided by: Allogene Therapeutics; Bristol Myers Squibb; CRISPR Therapeutics Ltd; Janssen Oncology & Legend Biotech; Kite, A Gilead Company and Novartis Pharmaceuticals Corp.